RU94012402A - METHOD OF TREATMENT INFRINGED SYNDROME - Google Patents

METHOD OF TREATMENT INFRINGED SYNDROME

Info

Publication number
RU94012402A
RU94012402A RU94012402/14A RU94012402A RU94012402A RU 94012402 A RU94012402 A RU 94012402A RU 94012402/14 A RU94012402/14 A RU 94012402/14A RU 94012402 A RU94012402 A RU 94012402A RU 94012402 A RU94012402 A RU 94012402A
Authority
RU
Russia
Prior art keywords
albumin
treatment
syndrome
therapy
dose
Prior art date
Application number
RU94012402/14A
Other languages
Russian (ru)
Other versions
RU2086256C1 (en
Inventor
А.Л. Бурмистрова
Т.А. Суслова
Э.А. Рыбин
А.К. Голикова
С.Г. Бурмистров
Original Assignee
Челябинский государственный технический университет
Filing date
Publication date
Application filed by Челябинский государственный технический университет filed Critical Челябинский государственный технический университет
Priority to RU94012402A priority Critical patent/RU2086256C1/en
Priority claimed from RU94012402A external-priority patent/RU2086256C1/en
Publication of RU94012402A publication Critical patent/RU94012402A/en
Application granted granted Critical
Publication of RU2086256C1 publication Critical patent/RU2086256C1/en

Links

Claims (1)

Изобретение относится к медицине, а именно к гастроэнторологии, и может быть использовано при лечении синдрома раздраженной кишки. Способ включает комплексную терапию с назначением транквилизаторов, препаратов, способствующих нормализации кишечной моторики, и бактериальных препаратов и витаминотерапию. Для повышения эффективности лечения с начала комплексной терапии осуществляют ректальное введение альбумина человеческого донорского в дозе 80 мл N 5 через два дня или специфической анти-HLA сыворотки против антигенов 1 класса, разведенной альбумином человеческим донорским, в дозе 80 мл N 3 через два дня. Клинический эффект, достигнутый при ректальном введении альбумина и специфической анти-HLA сыворотки против антигенов 1 класса обусловлен альбумином, который способен выступать в качестве местного иммуномодулятора.The invention relates to medicine, namely to gastroenterology, and can be used in the treatment of irritable bowel syndrome. The method includes a combination therapy with the appointment of tranquilizers, drugs that promote the normalization of intestinal motility, and bacterial drugs and vitamin therapy. To increase the effectiveness of treatment, from the beginning of the complex therapy, human donor albumin is administered rectally at a dose of 80 ml N 5 after two days or with specific anti-HLA serum against class 1 antigens diluted with human donor albumin at a dose of 80 ml N 3 after two days. The clinical effect achieved with rectal administration of albumin and specific anti-HLA serum against class 1 antigens is due to albumin, which is able to act as a local immunomodulator.
RU94012402A 1994-04-07 1994-04-07 Method for treating irritated intestine syndrome RU2086256C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94012402A RU2086256C1 (en) 1994-04-07 1994-04-07 Method for treating irritated intestine syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94012402A RU2086256C1 (en) 1994-04-07 1994-04-07 Method for treating irritated intestine syndrome

Publications (2)

Publication Number Publication Date
RU94012402A true RU94012402A (en) 1995-12-27
RU2086256C1 RU2086256C1 (en) 1997-08-10

Family

ID=20154486

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94012402A RU2086256C1 (en) 1994-04-07 1994-04-07 Method for treating irritated intestine syndrome

Country Status (1)

Country Link
RU (1) RU2086256C1 (en)

Similar Documents

Publication Publication Date Title
NO20100061L (en) Prevention and treatment of amyloidogenic disease
ATE228373T1 (en) SUPPRESSION OF AUTOIMMUNE DISEASES BY ANTIGENS IN WAITING
ES2040232T3 (en) MEDICINAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING A SINGLE DOSE OF 10 TO 240 MG OF DIHIDROPIRIDINA.
EP1019072A4 (en) Method for assisting in differential diagnosis and treatment of autistic syndromes
NO940376D0 (en) Dosage device for delivery of drug over a short period of time
KR950031063A (en) Using pravastatin to slow the progression of coronary atherosclerosis
RU94012402A (en) METHOD OF TREATMENT INFRINGED SYNDROME
FR2600256B1 (en) DRUG AND DRUG COMPOSITION FOR THE TREATMENT OF TUMORS AND FOR THE TREATMENT OF VIRUS-INFECTIOUS DISEASES
EA199800770A1 (en) DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS
Alcorn Slow progress against HIV
Scupham et al. Caribbean Sponge—Related Pseudomonas Folliculitis
RU92013754A (en) COLLECTION OF MEDICINAL HERBS, TAKING A GENERAL STRENGTHENING ACTION "ZODIAC SIGNS"
RU1826911C (en) Method of prophylaxis and treating atherosclerosis in experiment
RU94036169A (en) Method for treating hepatitis
Smith et al. Rubella and juvenile chronic arthritis.
RU96119817A (en) METHOD FOR TREATING INTESTINAL DYSBACTERIOSIS
RU94019564A (en) Method of gastroenteric diseases treatment
Pramanik Reiter's disease
RU94006632A (en) METHOD OF TREATING NON-SPECIFIC ULCEROUS COLITIS
RU94016144A (en) Agent for treatment patient with reiter's disease
RU94004938A (en) METHOD OF TREATING HEPATITIS
Gnaiger Allergic asthma
RU92001064A (en) METHOD OF MODELING THE SECONDARY IMMUNODEFICIENCY CONDITION
石学敏 et al. 30 CASES OF “PULSELESS DISEASE” TREATED WITH ACUPUNCTURE
RU93008438A (en) METHOD OF TREATING ACUTE RESPIRATORY DISEASES